Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
AlloVir (ALVR)
NASDAQ:ALVR
AlloVir (ALVR) Stock Price & Analysis
161 Followers
ALVR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.17 - $10.29
Previous Close$5.78
Volume249.19K
Average Volume (3M)243.15K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$264.11M
Total Debt (Recent Filing)$21.67M
Price to Earnings (P/E)-2.1
Beta0.23
Next EarningsFeb 09, 2023
EPS Estimate-$0.51
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$20.67
EPS (TTM)-2.78
Shares Outstanding62,669,373
R-Squared0.04
Standard Deviation0.24
10 Day Avg. Volume206,241
30 Day Avg. Volume243,146
Price to Book (P/B)1.88
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside243.93% Upside
Rating ConsensusStrong Buy
Alpha-0.03
Number of Analyst Covering3
AlloVir News
ALVR FAQ
What was AlloVir’s price range in the past 12 months?
AlloVir lowest stock price was $3.17 and its highest was $10.29 in the past 12 months.
What is AlloVir’s market cap?
Currently, no data Available
When is AlloVir’s upcoming earnings report date?
AlloVir’s upcoming earnings report date is Feb 09, 2023 which is in 7 days.
How were AlloVir’s earnings last quarter?
AlloVir released its earnings results on Nov 03, 2022. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.517 by $0.017.
Is AlloVir overvalued?
According to Wall Street analysts AlloVir’s price is currently Undervalued.
Does AlloVir pay dividends?
AlloVir does not currently pay dividends.
What is AlloVir’s EPS estimate?
AlloVir’s EPS estimate is -$0.51.
How many shares outstanding does AlloVir have?
AlloVir has 93,162,964 shares outstanding.
What happened to AlloVir’s price movement after its last earnings report?
AlloVir reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.517. Following the earnings report the stock price went down -1.28%.
Which hedge fund is a major shareholder of AlloVir?
Among the largest hedge funds holding AlloVir’s share is GMT Capital Corp. It holds AlloVir’s shares valued at 22M.
---
AlloVir Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.67
$20.67
Hedge Fund Trend
Increased
By 880.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.7%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.14%
12-Months-Change
Fundamentals
Return on Equity
-72.43%
Trailing 12-Months
Asset Growth
-7.21%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AlloVir
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.
---
iTeos Therapeutics
―
Mirum Pharmaceuticals
―
Editas Medicine
―
Allakos
―
Mersana Therapeutics
―
---